Cargando…

Use of Tofacitinib in the Context of COVID‐19 Vaccination: Comment on the American College of Rheumatology Clinical Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases

Detalles Bibliográficos
Autores principales:	Mortezavi, Mahta, Menon, Sujatha, Lee, Kristen, Rivas, Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239861/ https://www.ncbi.nlm.nih.gov/pubmed/34042319 http://dx.doi.org/10.1002/art.41806

Ejemplares similares

COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology
por: Park, Jin Kyun, et al.
Publicado: (2021)

Rheumatology Patient Satisfaction With Telemedicine During the COVID-19 Pandemic in the United States
por: Mortezavi, Mahta, et al.
Publicado: (2021)

Clinical scenarios-based guide for tofacitinib in rheumatoid arthritis
por: Mortezavi, Mahta, et al.
Publicado: (2023)

Erratum: Correction of Authors' Name Spelling in the Article “COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology”
por: Park, Jin Kyun, et al.
Publicado: (2021)

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
por: Sattui, Sebastian Eduardo, et al.
Publicado: (2021)

Fracture in clinical studies of tofacitinib in rheumatoid arthritis
por: Hansen, Karen E., et al.
Publicado: (2022)

Comment to: Teleconsultation of infant rheumatology in COVID-19 time
por: Qanneta, Rami
Publicado: (2023)

Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force
por: Tavares, Anna Carolina Faria Moreira Gomes, et al.
Publicado: (2022)

COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
por: Putman, Michael, et al.
Publicado: (2022)

Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
por: DiIorio, Michael, et al.
Publicado: (2022)

Update to “guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force”
por: Tavares, Anna Carolina Faria Moreira Gomes, et al.
Publicado: (2022)

Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance
por: Karpouzas, George A., et al.
Publicado: (2023)

Comment on the article “Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology”
por: Żuber, Zbigniew
Publicado: (2018)

Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries
por: Gianfrancesco, Milena A, et al.
Publicado: (2020)

COVID-19 vaccination in individuals with inflammatory rheumatic diseases
por: Skapenko, Alla, et al.
Publicado: (2022)

Willingness of college students to receive COVID-19 heterologous vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months
por: Karaarslan, Fatih, et al.
Publicado: (2021)

The COVID‐19 vaccine: Attitudes and vaccination in patients with autoimmune inflammatory rheumatic diseases
por: Chen, Jiali, et al.
Publicado: (2022)

Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19
por: Maslennikov, Roman, et al.
Publicado: (2021)

Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination
por: Specker, Christof, et al.
Publicado: (2021)

C-Reactive protein rise in rheumatology patients following COVID-19 vaccination
por: Gor, Shivani, et al.
Publicado: (2023)

COVID-19 vaccines and retinal microvasculature: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Comment on Determinants of the Attitude to COVID-19 Vaccine
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Update on COVID-19 vaccines and autoimmune-mediated rheumatic diseases
por: Suresh, Lakshmanan
Publicado: (2021)

Autoimmune inflammatory rheumatic diseases post-COVID‐19 vaccination
por: Safary, Azam, et al.
Publicado: (2022)

How do COVID-19 vaccines affect rheumatic diseases?
por: Altan, Lale, et al.
Publicado: (2022)

Predictors of hospitalization in patients with rheumatic disease and COVID-19 in Ireland: data from the COVID-19 global rheumatology alliance registry
por: Conway, Richard, et al.
Publicado: (2021)

The global challenges and opportunities in the practice of rheumatology: White paper by the World Forum on Rheumatic and Musculoskeletal Diseases
por: Al Maini, Mustafa, et al.
Publicado: (2014)

Effects of the second dose of COVID-19 vaccines in patients with autoimmune rheumatic diseases with hybrid immunity
por: Menon, Aparna R., et al.
Publicado: (2022)

COVID-19 vaccine hesitancy and influence of professional medical guidance
por: Nair, Govind, et al.
Publicado: (2022)

SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry
por: Liew, Jean, et al.
Publicado: (2022)

COVID-19 Vaccination Intention and Vaccine Hesitancy among Patients with Autoimmune and Autoinflammatory Rheumatological Diseases: A Survey
por: Tharwat, Samar, et al.
Publicado: (2022)

The impact of COVID-19 on rheumatology training—results from the COVID-19 Global Rheumatology Alliance trainee survey
por: Young, Kristen, et al.
Publicado: (2022)

Virtual rheumatology appointments during the COVID-19 pandemic: an international survey of perspectives of patients with rheumatic diseases
por: Howren, Alyssa, et al.
Publicado: (2020)

Persistent post-discharge symptoms after COVID-19 in rheumatic and musculoskeletal diseases
por: Leon, Leticia, et al.
Publicado: (2022)

Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry
por: Conway, Richard, et al.
Publicado: (2022)

Comment on: “Willingness to Pay for a COVID-19 Vaccine”
por: Sprengholz, Philipp, et al.
Publicado: (2021)

Comment on: COVID-19 vaccine-associated reactivation of uveitis
por: Sanjay, Srinivasan, et al.
Publicado: (2022)

Comment on “Multibacillary leprosy unmasked by COVID-19 vaccination”
por: Hanumanthu, Vinod, et al.
Publicado: (2022)

COVID-19 vaccine-associated autoimmune disorders: Comments
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e947berhqnld9fudd6qjkhdri5